BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Diabetes. Feb 15, 2026; 17(2): 112859
Published online Feb 15, 2026. doi: 10.4239/wjd.v17.i2.112859
Figure 2
Figure 2 Differences in bile acid levels among the healthy control, type 2 diabetes mellitus, and diabetic gastric autonomic neuropathy groups. A: Cholic acid; B: Deoxycholic acid; C: Chenodeoxycholic acid; D: Ursodeoxycholic acid; E: Lithocholic acid; F: Glycocholic acid; G: Glycodeoxycholic acid; H: Glycochenodeoxycholic acid; I: Glycoursodeoxycholic acid; J: Glycolithocholic acid; K: Taurocholic acid; L: Taurodeoxycholic acid; M: Taurochenodeoxycholic acid; N: Tauroursodeoxycholic acid; O: Taurolithocholic acid. Data are presented as the median (interquartile range), and significant difference was assessed using Wilcoxon’s rank sum test. aP < 0.05; bP < 0.01. T2DM: Type 2 diabetes mellitus; HC: Healthy control; DGAN: Diabetic gastric autonomic neuropathy; CA: Cholic acid; DCA: Deoxycholic acid; CDCA: Chenodeoxycholic acid; UDCA: Ursodeoxycholic acid; LCA: Lithocholic acid; GCA: Glycocholic acid; GDCA: Glycodeoxycholic acid; GCDCA: Glycochenodeoxycholic acid; GUDCA: Glycoursodeoxycholic acid; GLCA: Glycolithocholic acid; TCA: Taurocholic acid; TDCA: Taurodeoxycholic acid; TCDCA: Taurochenodeoxycholic acid; TUDCA: Tauroursodeoxycholic acid; TLCA: Taurolithocholic acid.


Write to the Help Desk